Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Early Prediction of Moderate-Severe Chronic GvHD By Immunity Related Transcriptome

Amit Kalra, MBBS, MSc, Poonam Dharmani-Khan, PhD, Stuti Patel, BHSc, Rehan Mujeeb Faridi, PhD, Victor A. Lewis, MD, Andrew Daly, MD, Adnan Mansoor, MDPhD, Meer-Taher Shabani-Rad, MD, Jan Storek, MD PhD, Faisal M Khan, PhD D (ABHI)

Blood (2018) 132 (Supplement 1): 70.

https://doi.org/10.1182/blood-2018-99-119926

Published: 2018

Journal Articles

High Pre-HCT Exposure to Thymoglobulin Is Associated with a Low Incidence of Relapse

Rosy Dabas, BSc, MSc, Kareem Jamani, MD, Bill Kangarloo, M.Sc, Poonam Dharmani-Khan, PhD, Don Morris, MD PhD FRCPC, Douglas Mahoney, PhD, Andrew Daly, MD, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2018) 132 (Supplement 1): 4605.

https://doi.org/10.1182/blood-2018-99-117332

Published: 2018

Journal Articles

Prediction of Severe Acute Graft-Versus-Host Disease (aGVHD) Based on Whole Transcriptome Sequencing of Donor CD4 T Cells

Silvy Lachance, MDFRCPC, Jonathan Séguin, MSc., Ann Brasey, PhD, Jean-Philippe Laverdure, PhD, Vincent T Ho, MD, Jerome Ritz, MD, Jan Storek, MD PhD, Denis-Claude Roy, MD, Lambert Busque, MD, Sébastien Lemieux, PhD, Claude Perreault, MD

Blood (2017) 130 (Supplement 1): 3249.

https://doi.org/10.1182/blood.V130.Suppl_1.3249.3249

Published: 2017

Journal Articles

Intermediate Post-HCT Exposure to Thymoglobulin Minimizes Mortality and High Exposure Minimizes the Composite of Death, Relapse or Chronic Graft-Versus-Host Disease

Kareem Jamani, MD, Rosy Dabas, BSc, MSc, Poonam Dharmani-Khan, PhD, Andrew Daly, MD, Jan Storek, MD PhD

Blood (2017) 130 (Supplement 1): 3245.

https://doi.org/10.1182/blood.V130.Suppl_1.3245.3245

Published: 2017

Journal Articles

Rabbit Anti-Thymocyte Globulin Kills Leukemic Stem Cells to a Greater Degree Than Healthy Hematopoietic Stem Cells

Rosy Dabas, BSc, MSc, Poonam Dharmani-Khan, PhD, Monica Modi, MD, Tiffany Van Slyke, MD, Joanne Luider, BSc, ART, MLT, Joseph M. Brandwein, MD FRCPC, Don Morris, MD PhD FRCPC, Andrew Daly, MD, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2017) 130 (Supplement 1): 5511.

https://doi.org/10.1182/blood.V130.Suppl_1.5511.5511

Published: 2017

Journal Articles

Anti-Thymocyte Globulin Kills Leukemic Stem Cells in Vitro

Rosy Dabas, M.Sc., B.Sc., Poonam Dharmani, PhD, Monica Modi, MD, Tiffany Van Slyke, Joanne Luider, Joseph M. Brandwein, MD FRCPC, Don Morris, Andrew Daly, MD FRCPC, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2016) 128 (22): 4616.

https://doi.org/10.1182/blood.V128.22.4616.4616

Published: 2016

Journal Articles

Differential Expression of Immunity Related Genes and Early Prediction of Severe Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Poonam Dharmani-Khan, PhD, Rehan Mujeeb Faridi, PhD, Ariz Akhter, PhD, Amit Kalra, MBBS, MS, Jan Storek, MD PhD, Faisal M Khan, PhD D (ABHI)

Blood (2016) 128 (22): 4576.

https://doi.org/10.1182/blood.V128.22.4576.4576

Published: 2016

Journal Articles

Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination

Kareem Jamani, MD, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 1963.

https://doi.org/10.1182/blood.V126.23.1963.1963

Published: 2015

Journal Articles

Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts

Rosy Dabas, Rachelle Lee, Maria Theresa Servito, Poonam Dharmani Khan, Monica Modi, MD, Tiffany Van Slyke, Joanne Luider, Caylib Durand, Loree Larratt, MD, Joseph Brandwein, MD FRCPC, Andrew Daly, MD FRCPC, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2015) 126 (23): 5481.

https://doi.org/10.1182/blood.V126.23.5481.5481

Published: 2015

Journal Articles

Cytomegalovirus (CMV) Serostatus: High Importance of Choosing Seropositive Donors for Seropositive Patients When Using Rabbit Antithymocyte Globulin (ATG)

Amit Kalra, MBBS, MS, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 4402.

https://doi.org/10.1182/blood.V126.23.4402.4402

Published: 2015

Journal Articles

Copies of Donor Killer Immunoglobulin-like Receptor Genes and Motifs Titrate Natural Killer (NK) Cells' Functional Response to Epstein - Barr Virus Infections and Influence the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Cell Transplantation

Rehan Mujeeb Faridi, PhD, Taylor J Kemp, B.HSc, Poonam Dharmani, PhD, Victor A. Lewis, MD, Noureddine Berka, PhD D (ABHI), Jan Storek, MD PhD, Faisal M Khan, PhD D (ABHI)

Blood (2015) 126 (23): 741.

https://doi.org/10.1182/blood.V126.23.741.741

Published: 2015

Journal Articles

Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab

Amit Kalra, MBBS, MS, Cameron Roessner, BScPharm, Jennifer Jupp, BScPharm,BCOP, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 3114.

https://doi.org/10.1182/blood.V126.23.3114.3114

Published: 2015

Journal Articles

Influence of Fludarabine Pharmacokinetics on Outcome of Allogeneic Stem Cell Transplantation with Fludarabine-Busulfan Conditioning

Mita Manna, MD FRCPC, Andrew Daly, MD FRCPC, Bill Kangarloo, Mary Lynn Savoie, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 3119.

https://doi.org/10.1182/blood.V126.23.3119.3119

Published: 2015

Journal Articles

BK Virus Hemorrhagic Cystitis Is Associated with Graft Versus Host Disease and Increased Health Care Resource Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation

Wilson Lam, MD, Jan Storek, MD PhD, Nizar J Bahlis, MD, Christopher Brown, MD, Peter Duggan, MD FRCPC, Michelle Geddes, MD FRCPC, Mary Lynn Savoie, MD FRCPC, Mona Shafey, MD FRCPC, Douglas A. Stewart, MD FRCPC, Andrew Daly, MD FRCPC

Blood (2014) 124 (21): 3901.

https://doi.org/10.1182/blood.V124.21.3901.3901

Published: 2014

Journal Articles

Influence of Production Affecting Cytokine Genetic Variants on Allogeneic Hematopoietic Cell Transplantation Outcomes

Gaurav Tripathi, PhD, Poonam D Khan, PhD, Rehan M Faridi, PhD, Victor Lewis, MD, Noureddine Berka, PhD D (ABHI), Jan Storek, MD PhD, Faisal M Khan, PhD D (ABHI)

Blood (2014) 124 (21): 1091.

https://doi.org/10.1182/blood.V124.21.1091.1091

Published: 2014

Journal Articles

Fludarabine Metabolite Level On Day Zero Does Not Affect Outcomes Of Hematopoietic Cell Transplantation In Patients With Normal Renal Function

Cameron D. Griffiths, MD, Ella S.M Ng, MSc., Bill Kangarloo, MSc., Tyler S Williamson, PhD, Reanne Booker, BSc, MSN, NP, Ping Yue, MD, Peter Duggan, MD, FRCPC, Mary Lynn Savoie, MD, FRCPC, Christopher Brown, MD, Andrew Daly, MD, FRCPC, James A Russell, MD, Jan Storek, MD, PhD

Blood (2013) 122 (21): 2116.

https://doi.org/10.1182/blood.V122.21.2116.2116

Published: 2013

Journal Articles

Donor-Recipient Matching For Killer Immunoglobulin-Like Receptor Genotypes Confers Protection Against Graft Versus Host Disease Without Affecting Disease Relapse After Allogeneic Hematopoietic Cell Transplantation

Rehan M Faridi, PhD, Taylor J Kemp, Victor A. Lewis, MD, Noureddine Berka, PhD, Jan Storek, MD, PhD, Faisal Khan, PhD

Blood (2013) 122 (21): 4628.

https://doi.org/10.1182/blood.V122.21.4628.4628

Published: 2013

Journal Articles

Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis

Jan Storek, MD, PhD, Rob Woolson, MS, Paul K. Wallace, MS, PhD, Gregory Sempowski, MD, Peter A. McSweeney, MD, Maureen Mayes, MD, Leslie Crofford, MD, Sharon LeClercq, MD, Richard A. Nash, MD, Keith M. Sullivan, MD

Blood (2011) 118 (21): 4917.

https://doi.org/10.1182/blood.V118.21.4917.4917

Published: 2011

Journal Articles

Immune Reconstitution After Antithymocyte Globulin (ATG)-Conditioned Hematopoietic Cell Transplantation (HCT)

Mark Bosch, MD, FRCPC, Manveer Dhadda, Mette Hoegh-Petersen, MD, Yiping Liu, Laura M Hagel, Peter Podgorny, Alejandra Ugarte-Torres, MD, Joanne Luider, Iwona Auer-Grzesiak, MD, FRCPC, Adnan Mansoor, MD, FRCPC, James A Russell, Jan Storek, MD, PhD

Blood (2011) 118 (21): 1981.

https://doi.org/10.1182/blood.V118.21.1981.1981

Published: 2011

Journal Articles

Anti-GvHD Effect of Antithymocyte Globulin Is Mediated by Antibodies Binding to T Cells and Regulatory NK Cells, and Less So or Not at All by Antibodies Binding to Other Mononuclear Cell Subsets

Mette Hoegh-Petersen, MD, Minaa Amin, Yiping Liu, Alejandra Ugarte-Torres, Tyler S Williamson, Peter Podgorny, James A Russell, Jan Storek, MD, PhD

Blood (2010) 116 (21): 2346.

https://doi.org/10.1182/blood.V116.21.2346.2346

Published: 2010

NARROW

Early Prediction of Moderate-Severe Chronic GvHD By Immunity Related Transcriptome

High Pre-HCT Exposure to Thymoglobulin Is Associated with a Low Incidence of Relapse

Prediction of Severe Acute Graft-Versus-Host Disease (aGVHD) Based on Whole Transcriptome Sequencing of Donor CD4 T Cells

Intermediate Post-HCT Exposure to Thymoglobulin Minimizes Mortality and High Exposure Minimizes the Composite of Death, Relapse or Chronic Graft-Versus-Host Disease

Rabbit Anti-Thymocyte Globulin Kills Leukemic Stem Cells to a Greater Degree Than Healthy Hematopoietic Stem Cells

Anti-Thymocyte Globulin Kills Leukemic Stem Cells in Vitro

Differential Expression of Immunity Related Genes and Early Prediction of Severe Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination

Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts

Cytomegalovirus (CMV) Serostatus: High Importance of Choosing Seropositive Donors for Seropositive Patients When Using Rabbit Antithymocyte Globulin (ATG)

Copies of Donor Killer Immunoglobulin-like Receptor Genes and Motifs Titrate Natural Killer (NK) Cells' Functional Response to Epstein - Barr Virus Infections and Influence the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Cell Transplantation

Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab

Influence of Fludarabine Pharmacokinetics on Outcome of Allogeneic Stem Cell Transplantation with Fludarabine-Busulfan Conditioning

BK Virus Hemorrhagic Cystitis Is Associated with Graft Versus Host Disease and Increased Health Care Resource Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation

Influence of Production Affecting Cytokine Genetic Variants on Allogeneic Hematopoietic Cell Transplantation Outcomes

Fludarabine Metabolite Level On Day Zero Does Not Affect Outcomes Of Hematopoietic Cell Transplantation In Patients With Normal Renal Function

Donor-Recipient Matching For Killer Immunoglobulin-Like Receptor Genotypes Confers Protection Against Graft Versus Host Disease Without Affecting Disease Relapse After Allogeneic Hematopoietic Cell Transplantation

Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis

Immune Reconstitution After Antithymocyte Globulin (ATG)-Conditioned Hematopoietic Cell Transplantation (HCT)

Anti-GvHD Effect of Antithymocyte Globulin Is Mediated by Antibodies Binding to T Cells and Regulatory NK Cells, and Less So or Not at All by Antibodies Binding to Other Mononuclear Cell Subsets

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only